i2i Academy – From Idea to IND
i2i Academy
From Idea to IND
Navigating the critical decisions that shape success
A half-day educational forum for teams advancing mammalian biologics and ADCs toward the clinic.
Bringing a promising therapy to the clinic is exciting, but the journey from that idea to IND is shaped by a series of critical decisions that can influence development success.
Join Lonza experts, industry leaders and fellow biotech innovators for an afternoon of practical insights, real-world experiences and meaningful connections. Focused on mammalian biologics and antibody-drug conjugates (ADCs), the program will explore key considerations across drug substance and drug product, including CMC, manufacturability, formulation and regulatory strategy.
What to expect
✓ Expert presentations on key IND-enabling considerations
✓ Industry case studies and lessons learned
✓ Interactive discussions with leaders across the biotech ecosystem
✓ Exclusive tour of Lonza’s drug product development facilities
✓ Networking with peers, partners and industry experts
Date
Monday, 12 October 2026
Timing
i2i Academy: 13:00–17:30 CEST
Evening Networking Reception: 18:00–21:30 CEST
Location
i2i Academy
Building G/F
Stücki Technology Park
Hochbergerstrasse 60
4057 Basel, Switzerland
Stücki Technology Park
Hochbergerstrasse 60
4057 Basel, Switzerland
Evening Networking Reception
Location to be confirmed
Transportation will be provided from Lonza’s Stucki campus to the reception venue.
